|
Volumn 44, Issue 3, 2012, Pages 797-801
|
The relationship between recurrences and immunosuppression on living donor liver transplantation for hepatocellular carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
BASILIXIMAB;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RITUXIMAB;
STEROID;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
ARTICLE;
BLOOD GROUP ABO SYSTEM;
CANCER PATIENT;
CLINICAL ARTICLE;
COHORT ANALYSIS;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER CELL CARCINOMA;
LIVER RESECTION;
LIVER TRANSPLANTATION;
LIVING DONOR;
MALE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RECURRENCE RISK;
RISK FACTOR;
SURVIVAL RATE;
TREATMENT OUTCOME;
CARCINOMA, HEPATOCELLULAR;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER NEOPLASMS;
LIVER TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGED;
RECURRENCE;
|
EID: 84859507679
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2012.01.012 Document Type: Article |
Times cited : (11)
|
References (9)
|